Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurberry Regulatory News (BRBY)

Share Price Information for Burberry (BRBY)

Share Price is delayed by 15 minutes
Get Live Data
1,137.50    20.50 (1.84%)
Bid:
1,129.50
Ask:
1,132.50
Spread: 3.00 (0.266%)
Market Cap: £4.09b
BRBY Live PriceLast checked at - London Stock Exchange

Intraday Burberry Share Chart

Board Changes

18 Dec 2024 16:00

RNS Number : 6391Q
Burberry Group PLC
18 December 2024
 

BURBERRY GROUP PLC

 

BOARD CHANGES

 

Burberry Group plc (the "Company") is pleased to announce the following Board changes:

 

Stella King has been appointed to the Board as an independent Non-Executive Director and member of the Nomination Committee, with effect from 1 April 2025.

 

Stella is currently at Moncler which she joined thirteen years ago in 2011 as President, Asia Pacific. In January 2022 she moved to the role of Chief Chinese Business Officer and will step down from that role on 31 December 2024. She also served as a Non-Executive Director of Moncler subsidiary Stone Island between March 2021 and April 2024. Earlier in her career, Stella served as President, Asia Pacific for Sergio Rossi and also held various managerial positions at Lane Crawford in Mainland China.

 

The Company confirms there is no further information to be disclosed pursuant to LR 6.4.8 R in relation to Stella King's appointment.

 

Fabiola Arredondo and Antoine de Saint-Affrique will retire from the Board as Non-Executive Directors following the AGM to be held in July 2025.

 

Fabiola has served as a member of the Remuneration and Nomination Committees since her appointment on 10 March 2015. She is a former Chair of the Remuneration Committee and has also served as a member of the Audit Committee. Antoine joined the Board on 1 January 2021 and has been a member of the Audit and Nomination Committees since that date. Fabiola and Antoine will continue to serve as committee members until their retirement from the Board.

 

Gerry Murphy, Burberry Chair, said:

 

"Stella has impressive and deep understanding of the luxury market and consumers in the Asia Pacific region. Her insight and expertise will be a great asset to Burberry and we are delighted that she has accepted our invitation to join the Burberry Board."

 

"On behalf of the Board, I want to thank Fabiola and Antoine for their service to the Company. The Board has benefitted greatly from their extensive knowledge and experience throughout their tenures and I wish them both every success in their future endeavours."

 

18 December 2024

 

Enquiries

 

Investors and analysts

Lauren Wu Leng

Head of Investor Relations

020 3425 2007

Lauren.Wuleng@burberry.com

 

Media

 

 

Andrew Roberts

SVP, Corporate Relations and Engagement

020 3367 3764

Andrew.Roberts@burberry.com

 

This announcement does not constitute an invitation to underwrite, subscribe for or otherwise acquire or dispose of any Burberry Group plc shares, in the UK, or in the US, or under the US Securities Act 1933 or in any other jurisdiction.

Burberry is listed on the London Stock Exchange (BRBY.L) and is a constituent of the FTSE 250 index. ADR symbol OTC:BURBY. 

BURBERRY, the Equestrian Knight Device, the Burberry Check and the Thomas Burberry Monogram and Print are trademarks belonging to Burberry.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWVVRSNUUAAA
Date   Source Headline
18th Jul 20257:00 amRNSFirst Quarter Trading Update
16th Jul 20252:15 pmRNSResult of AGM
3rd Jul 20255:36 pmRNSHolding(s) in Company
1st Jul 202511:17 amRNSHolding(s) in Company
1st Jul 202510:56 amRNSTotal Voting Rights
27th Jun 20251:00 pmRNSDirector/PDMR Shareholding
4th Jun 20255:27 pmRNSHolding(s) in Company
2nd Jun 20252:50 pmRNSTotal Voting Rights
29th May 202512:47 pmRNSAnnual Financial Report
14th May 20257:00 amRNSBurberry FY25 Preliminary Results
2nd May 20253:28 pmRNSDirectorate Change
1st May 202511:26 amRNSTotal Voting Rights
1st Apr 20253:58 pmRNSHolding(s) in Company
1st Apr 20252:37 pmRNSTotal Voting Rights
3rd Mar 20252:26 pmRNSBlock listing Interim Review
3rd Mar 20252:20 pmRNSTotal Voting Rights
3rd Feb 202510:28 amRNSTotal Voting Rights
24th Jan 20257:00 amRNSThird Quarter Trading Update
16th Jan 20254:25 pmRNS2024 Annual General Meeting Voting Outcome Update
2nd Jan 202510:41 amRNSTotal Voting Rights
20th Dec 20243:33 pmRNSDirector/PDMR Shareholding
18th Dec 20244:00 pmRNSBoard Changes
12th Dec 20245:40 pmRNSDirector/PDMR Shareholding
3rd Dec 20241:58 pmRNSPublication of a Prospectus
2nd Dec 202411:31 amRNSTotal Voting Rights
14th Nov 20247:00 amRNSBurberry Interim Results
1st Nov 202411:59 amRNSTotal Voting Rights
1st Oct 20241:01 pmRNSTotal Voting Rights
19th Sep 20246:18 pmRNSHolding(s) in Company - Correction
2nd Sep 20246:03 pmRNSBlock listing Interim Review
2nd Sep 20245:36 pmRNSHolding(s) in Company
2nd Sep 202412:23 pmRNSTotal Voting Rights
15th Aug 20244:35 pmRNSTotal Voting Rights
6th Aug 202412:28 pmRNSDirector Declaration
5th Aug 20246:27 pmRNSDirector/PDMR Shareholding - Correction
5th Aug 20245:54 pmRNSDirector/PDMR Shareholding
1st Aug 202410:17 amRNSTotal Voting Rights
31st Jul 202410:25 amRNSDirector/PDMR Shareholding
30th Jul 20246:04 pmRNSDirector/PDMR Shareholding
18th Jul 20242:45 pmRNSDirector/PDMR Shareholding
17th Jul 20243:53 pmRNSDirector/PDMR Shareholding
16th Jul 20245:02 pmRNSResult of AGM
16th Jul 20244:52 pmRNSDirector/PDMR Shareholding
16th Jul 20249:36 amRNSDirector/PDMR Shareholding
16th Jul 20249:34 amRNSDirector/PDMR Shareholding
16th Jul 20249:17 amRNSDirector/PDMR Shareholding
15th Jul 20247:00 amRNSBoard Change
15th Jul 20247:00 amRNSFirst Quarter Trading Update
1st Jul 202410:03 amRNSTotal Voting Rights
20th Jun 20243:55 pmRNSPublication of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.